Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

作者: Natalie B. Vinh , Jamie S. Simpson , Peter J. Scammells , David K. Chalmers

DOI: 10.1007/S10822-012-9569-7

关键词:

摘要: We have used virtual screening to develop models for the binding of aryl substituted heterocycles p38α MAPK. Virtual was conducted on a number MAPK crystal structures using library 46 known inhibitors containing heterocyclic core by pyridine and fluorophenyl rings (structurally related SB203580) set decoy compounds. Multiple protonation states tautomers active compounds were considered. Each docking model evaluated receiver operating characteristic (ROC) curves enrichment factors. The two best performing single found be 1BL7 2EWA, with factors 14.1 13.0 at 2 % screen respectively. Ensembles up four receptors similar conformations generated, generally giving good or very performances high ROC AUCs enrichment. 1BL7-2EWA ensemble able outperform each its constituent gave 17.3, 12.0, 8.0 2, 5 10 respectively, screen. A AUC 0.94 obtained this ensemble. This method may applied other proteins where there are large inhibitor classes different site conformations.

参考文章(80)
Roderick E. Hubbard, Structure-based drug discovery : an overview RSC Publishing. ,(2006)
Robin L. Thurmond, Scott A. Wadsworth, Peter H. Schafer, Robert A. Zivin, John J. Siekierka, Kinetics of small molecule inhibitor binding to p38 kinase FEBS Journal. ,vol. 268, pp. 5747- 5754 ,(2001) , 10.1046/J.0014-2956.2001.02512.X
Ana Cuenda, Simon Rousseau, p38 MAP-Kinases pathway regulation, function and role in human diseases Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. ,vol. 1773, pp. 1358- 1375 ,(2007) , 10.1016/J.BBAMCR.2007.03.010
Jane E. Sullivan, Geoffrey A. Holdgate, Douglas Campbell, David Timms, Stefan Gerhardt, Jason Breed, Alexander L. Breeze, Alun Bermingham, Richard A. Pauptit, Richard A. Norman, Kevin J. Embrey, Jon Read, Wendy S. VanScyoc, Walter H. J. Ward, Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase. Biochemistry. ,vol. 44, pp. 16475- 16490 ,(2005) , 10.1021/BI051714V
Stefan A. Laufer, Gerd K. Wagner, From Imidazoles to Pyrimidines: New Inhibitors of Cytokine Release Journal of Medicinal Chemistry. ,vol. 45, pp. 2733- 2740 ,(2002) , 10.1021/JM011098A
Stefan A. Laufer, Hans-Günther Striegel, Gerd K. Wagner, Imidazole inhibitors of cytokine release: probing substituents in the 2 position. Journal of Medicinal Chemistry. ,vol. 45, pp. 4695- 4705 ,(2002) , 10.1021/JM020873Z
Roger S. Armen, Jianhan Chen, Charles L. Brooks, An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics. Journal of Chemical Theory and Computation. ,vol. 5, pp. 2909- 2923 ,(2009) , 10.1021/CT900262T
Kenneth Down, Paul Bamborough, Catherine Alder, Amanda Campbell, John A. Christopher, Maria Gerelle, Steve Ludbrook, Dave Mallett, Geoff Mellor, David D. Miller, Rosannah Pearson, Keith Ray, Yemisi Solanke, Don Somers, The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase Bioorganic & Medicinal Chemistry Letters. ,vol. 20, pp. 3936- 3940 ,(2010) , 10.1016/J.BMCL.2010.05.011
Lisa Shewchuk, Anne Hassell, Bruce Wisely, Warren Rocque, William Holmes, James Veal, Lee F. Kuyper, Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. Journal of Medicinal Chemistry. ,vol. 43, pp. 133- 138 ,(2000) , 10.1021/JM990401T